Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.

The Prostate - 1 Dec 2011

Fachal Laura, Gómez-Caamaño Antonio, Celeiro-Muñoz Catuxa, Peleteiro Paula, Blanco Ana, Carballo Ana, Forteza Jerónimo, Carracedo Angel, Vega Ana

Abstract excerpt

BACKGROUND: Although in recent years deleterious BRCA1 mutations have been extensively studied as a prostate cancer risk factor, results are inconclusive. To assess the contribution of the BRCA1 Galician founder mutation c.211A>G in prostate cancer morbidity we conducted a case-control study. Moreover, to better elucidate whether deleterious BRCA1 mutations are involved in the development of prostate cancer, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to BRCA1 Protein

Share to BRCA1 gene

Share to Genetic Predisposition to Disease

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 21520156
DOI: 10.1002/pros.21394

Genes

BRCA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.PMID 21520156Read ↗

BRCA1 mutations and prostate cancer in Poland.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.Semantic proximity Read ↗

CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Contribution of HOGG1 Ser³²⁶Cys polymorphism to the development of prostate cancer in smokers: meta-analysis of 2779 cases and 3484 controls.Semantic proximity Read ↗

Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.Semantic proximity Read ↗

Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.Semantic proximity Read ↗

TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis.Semantic proximity Read ↗

Direct detection of the AR-E211 G > A gene polymorphism from blood and tissue samples without DNA isolation.Semantic proximity Read ↗

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.Semantic proximity Read ↗

Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis.Semantic proximity Read ↗

KLF6 IVS1 -27G>A variant and the risk of prostate cancer in Finland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.